Actavis, AstraZeneca resolve Crestor patent battle
Allens 2018-05-28 11:45 pm By Christine Caulfield | Melbourne
Please login to bookmark Close

Generic drug giant Actavis Global has reached a settlement with AstraZeneca in a long-running patent dispute over blockbuster cholesterol medicine Crestor that wound its way to the High Court.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au